InnovaRx Innova Health Strategies

P96.2

Withdrawal symptoms from therapeutic use of drugs in newborn

Billable FY2026 2025-10-01 → 2026-09-30
Exclusions 5 never code together
P00-P96chapter
Excludes2
  • congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)Q00-Q99
  • endocrine, nutritional and metabolic diseases (E00-E88)E00-E88
  • injury, poisoning and certain other consequences of external causes (S00-T88)S00-T88
  • neoplasms (C00-D49)C00-D49
  • tetanus neonatorum (A33)A33

Excludes2 — not included here, but the patient may have both. Code both when documented.

Instructional notes 2
P00-P96chapter
Notes
  • Codes from this chapter are for use on newborn records only, never on maternal records
Includes
  • conditions that have their origin in the fetal or perinatal period (before birth through the first 28 days after birth) even if morbidity occurs later
Index entries leading here 2
  • Withdrawal state — see also Dependence, drug by type, with withdrawal
    • newborn
      • correct therapeutic substance properly administered P96.2
    • therapeutic substance, neonatal P96.2
  • Syndrome — see also Disease
    • withdrawal — see Withdrawal, state
      • drug
        • therapeutic use, newborn P96.2
Alongside this code 6 same parent — P96
Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

CMS28HCC137

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2026
Parent
P96
Block
P90-P96
Siblings
6

Present FY2024–FY2027.